ILMN - Illumina Inc
IEX Last Trade
131.4
-2.380 -1.811%
Share volume: 968,710
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$133.78
-2.38
-1.78%
View ratios
| Fiscal Date | 2022-07-03 | 2022-10-02 | 2023-01-01 | 2023-04-02 | 2023-07-02 | 2023-10-01 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-04 | 2023-02-17 | 2023-05-05 | 2023-08-10 | 2023-11-13 | 2024-02-16 | 2024-05-03 | |
| Assets | |||||||||
| Total Assets | 15.448 B | 11.256 B | 12.252 B | 11.811 B | 11.774 B | 10.122 B | 10.111 B | 10.040 B | |
| Current Assets | 2.891 B | 2.487 B | 3.561 B | 3.172 B | 3.223 B | 2.506 B | 2.609 B | 2.583 B | |
| Inventories | 518.000 M | 559.000 M | 568.000 M | 586.000 M | 617.000 M | 615.000 M | 587.000 M | 584.000 M | |
| Other Current Assets | 404.000 M | 259.000 M | 285.000 M | 403.000 M | 306.000 M | 268.000 M | 234.000 M | 256.000 M | |
| Short Term Investments | 404.000 M | 259.000 M | 285.000 M | 403.000 M | 306.000 M | 268.000 M | 234.000 M | 256.000 M | |
| Total Receivables | 642.000 M | 628.000 M | 671.000 M | 665.000 M | 741.000 M | 690.000 M | 734.000 M | 635.000 M | |
| Current Cash | 1.327 B | 1.041 B | 2.037 B | 1.518 B | 1.559 B | 933.000 M | 1.054 B | 1.108 B | |
| Total Non-current Assets | 12.557 B | 8.769 B | 8.691 B | 8.639 B | 8.551 B | 7.616 B | 7.502 B | 7.457 B | |
| Property Plant Equipment | 1.055 B | 1.068 B | 1.091 B | 1.082 B | 1.069 B | 1.040 B | 1.007 B | 964.000 M | |
| Other Assets | 449.000 M | 448.000 M | 395.000 M | 423.000 M | 389.000 M | 411.000 M | 385.000 M | 430.000 M | |
| Intangible Assets | 3.202 B | 3.335 B | 3.285 B | 3.237 B | 3.188 B | 3.029 B | 2.993 B | 2.940 B | |
| Goodwill | 7.158 B | 3.238 B | 3.239 B | 3.239 B | 3.239 B | 2.527 B | 2.545 B | 2.545 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 15.448 B | 11.256 B | 12.252 B | 11.811 B | 11.774 B | 10.122 B | 10.111 B | 10.040 B | |
| Total liabilities | 5.004 B | 4.525 B | 5.653 B | 5.118 B | 5.219 B | 4.224 B | 4.366 B | 4.306 B | |
| Total current liabilities | 2.881 B | 2.669 B | 2.773 B | 2.230 B | 2.303 B | 1.482 B | 1.570 B | 1.474 B | |
| Accounts Payable | 282.000 M | 281.000 M | 293.000 M | 242.000 M | 244.000 M | 240.000 M | 245.000 M | 201.000 M | |
| Other liabilities | 853.000 M | 613.000 M | 649.000 M | 654.000 M | 702.000 M | 555.000 M | 620.000 M | 642.000 M | |
| Current long term debt | 1.245 B | 1.246 B | 1.248 B | 749.000 M | 750.000 M | 0.000 | 0.000 | 0.000 | |
| Long term debt | 495.000 M | 495.000 M | 1.487 B | 1.487 B | 1.488 B | 1.489 B | 1.489 B | 1.490 B | |
| Other liabilities | 853.000 M | 613.000 M | 649.000 M | 654.000 M | 702.000 M | 555.000 M | 620.000 M | 642.000 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 10.444 B | 6.731 B | 6.599 B | 6.693 B | 6.555 B | 5.898 B | 5.745 B | 5.734 B | |
| Common stock | 157.000 M | 157.000 M | 157.000 M | 158.000 M | 158.000 M | 158.000 M | 158.000 M | 159.000 M | |
| Retained earnings | 5.097 B | 1.281 B | 1.142 B | 1.145 B | 911.000 M | 157.000 M | -19.000 M | -145.000 M |